IRulya Therapeutics Inc. (IRLA) Stock

Healthcare · Biotechnology · Member of Other US Stocks

IRulya Therapeutics Inc. (IRLA) closed at USD 30.00 on 2026-10-14, a change of -91.3 % over the past year, with a market capitalization of USD 33.8M.

IRulya Therapeutics Inc. recent closing prices

DateClose (USD)
2026-10-1430.00
2026-10-1327.87
2026-10-1232.40
2026-10-0931.73
2026-10-0829.36
2026-10-0726.72
2026-10-0626.81

The most recent trading day is not shown. For full charts and indicators use the analysis page.

IRulya Therapeutics Inc. key figures

Previous close
USD 30.00 (2026-10-14)
1-year change
-91.3 %
Market cap
USD 33.8M
Enterprise value
USD 61.63M
P/E ratio (trailing)
n/a
P/E ratio (forward)
n/a
EPS (trailing)
n/a
EPS (forward)
n/a
PEG ratio
n/a
Price to book
n/a
Revenue growth
n/a
Earnings growth
n/a
Dividend per share (trailing)
n/a
Short ratio
2.92
Employees
38
Analyst consensus (third-party)
strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About IRulya Therapeutics Inc.

IRulya Therapeutics Inc., a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises eDSP, which is in Phase 3, for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consist of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. IRulya Therapeutics Inc. was formerly known as Quince Therapeutics, Inc. and changed its name to IRulya Therapeutics Inc. in October 2026. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for IRulya Therapeutics Inc. and compare it with other stocks.

Analyze IRLAAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell IRulya Therapeutics Inc. shares.